Buscar
Mostrando ítems 1-3 de 3
New Frontiers in Prostate Cancer Treatment: Are We Ready for Drug Combinations with Novel Agents?
(MDPI, 2020)
Medical treatment for metastatic castration-resistant prostate cancer (mCRPC) patients has progressively been evolving from a nonspecific clinical approach to genomics-oriented therapies. The scientific community is in ...
Current Strategies and Novel Therapeutic Approaches for Metastatic Urothelial Carcinoma
(MDPI, 2020)
Urothelial carcinoma (UC) is a frequent cause of cancer-related deaths worldwide. Metastatic UC has been historically associated with poor prognosis, with a median overall survival of approximately 15 months and a 5-year ...
Update on Circulating Tumor Cells in Genitourinary Tumors with Focus on Prostate Cancer
(MDPI, 2020)
Current developments in the treatment of genitourinary tumors underline the unmet clinical need for biomarkers to improve decision-making in a challenging clinical setting. The detection of circulating tumor cells (CTCs) ...